Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-03-14FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for Lopressor (metoprolol tartrate) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
This clinical trial update assesses whether ranolazine reduces myocardial ischemia detected by high-field 3T cardiovascular MRI and P-31 spe…
-
FDA approval · 2013-02-27FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate from Hospira, Inc., indicating an updated regulatory action on the generic p…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Extracorporeal Shockwave Therapy for the Treatment of Refractory Angina Pectoris [Phase 2]
Phase 2 clinical trial evaluating extracorporeal shockwave therapy for refractory angina pectoris has completed. The supplied snippet does n…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Extracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris [Phase 1]
A Phase 1 clinical trial evaluating Extracorporeal Shockwave Therapy for refractory angina pectoris has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-02-13Clinical Trial Update: Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization [Phase 3]
This document provides a Phase 3 clinical trial update on angiogenesis therapy for women with angina pectoris who are not candidates for rev…
-
FDA approval · 2013-02-01FDA Approved: NITROGLYCERIN IN DEXTROSE — Supplemental Application (Baxter Healthcare Company)
FDA approved Baxter's Supplemental Application for Nitroglycerin in Dextrose, adding this intravenous nitroglycerin formulation to the appro…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure [Phase 2, Phase 3]
This clinical trial update reports completion of Phase 2/3 testing of bypass surgery with CD133-positive marrow cell injections for ischemic…
-
FDA approval · 2013-01-10FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Nicardipine hydrochloride from Hikma Pharmaceuticals USA Inc., granting regulatory approval …
-
FDA approval · 2013-01-07FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for NORVASC (amlodipine besylate) submitted by Viatris Specialty LLC. The approval is related to…
-
CLINICAL_TRIALS research · 2012-12-20Clinical Trial Update: A Registry Study of Shuxuening Injection Used in Hospitals in China
A registry study in China evaluating Shuxuening Injection for cardiovascular and cerebrovascular conditions, with the current status not dis…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition [Phase 1]
Phase 1 bioequivalence study of Bisoprolol Fumarate 10 mg tablets under fed conditions has been completed. The study assesses bioequivalence…
-
FDA approval · 2012-12-07FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s generic diltiazem hydrochloride (ANDA 202463). The product is indicated for the management of hypertensi…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients [Phase 4]
Open-label Phase 4 study assessing long-term safety of Caduet in Japanese patients completed; results posted in 2012.
-
FDA approval · 2012-11-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc. for an already authorized product.
-
FDA label_change · 2012-11-16FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for NORVASC (amlodipine besylate) filed by Viatris Specialty LLC.
-
CLINICAL_TRIALS research · 2012-11-12Clinical Trial Update: Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT
Update on a clinical trial investigating cardiovascular molecular calcification using 18F-NaF PET/CT imaging. The study targets cardiovascul…
-
CLINICAL_TRIALS research · 2012-10-25Clinical Trial Update: Efficacy of Extracorporeal Shockwave Myocardial Revascularization [NA]
This clinical trial update assesses the efficacy of Extracorporeal Shockwave Myocardial Revascularization for refractory angina. The current…
-
FDA approval · 2012-08-24FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental abbreviated new drug application for diltiazem hydrochloride from Sun Pharmaceutical, a generic calcium channel …
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief [Phase 2]
Phase 2 trial results evaluated whether supplemental oxygen during percutaneous coronary intervention reduces pain for angina patients. The …
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM) [Phase 4]
Phase 4 trial evaluating the effects of ranolazine on exercise duration in patients with chronic stable angina and coronary artery disease w…
-
CLINICAL_TRIALS research · 2012-06-28Clinical Trial Update: Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol [Phase 4]
Phase 4 clinical trial update comparing ivabradine to carvedilol for ischemia in patients on hemodialysis.
-
CLINICAL_TRIALS research · 2012-06-06Clinical Trial Update: Safety Study of Kudiezi (a Chinese Medicine Injection) Used in Hospitals in China
An update on an ongoing safety study of Kudiezi (a Chinese medicine injection) used in hospitals in China for coronary heart disease and ang…
-
FDA approval · 2012-05-23FDA Approved: FELODIPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for felodipine submitted by Torrent Pharmaceuticals Limited, authorizing an update to an already app…
-
CLINICAL_TRIALS research · 2012-04-03Clinical Trial Update: Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris [Phase 1]
A Phase 1 clinical trial update evaluating Extracorporeal Shockwave Therapy for refractory chronic angina pectoris. The study is sponsored b…